← Back to all trials
Completed
NCT06687512
A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.
Conditions: Atopic Dermatitis
Sex: All
Ages: 6 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 44
Sponsor: NovoBliss Research Pvt Ltd
Location: NovoBliss Research Pvt Ltd Ahmedabad Gujarat
Summary
This is an exploratory, proof-of-concept, double-blind, placebo-controlled, randomized, comparative, interventional, prospective, safety in-use tolerability and efficacy study of test products in patients with mild to moderate Atopic Dermatitis.
Eligibility Criteria
Inclusion Criteria:
* 1\) Age: For children: 6 years and above (both inclusive) at the time of parental consent/assent and For Adults: 18 to 65 years (both inclusive) at the time of consent.
2\) Sex: Healthy children (male or female) and adults (males and non-pregnant/non-lactating females) with mild to moderate atopic dermatitis.
3\) Subject's with TEWL \>15% and Moisture level \
Source: ClinicalTrials.gov (NCT06687512). StuddyBuddy aggregates publicly available trial information.
